在息治疗中持续激动性妄想的比例镇静:随机临床试验
David Hui1, Allison De La Rosa1, Jaw-Shiun Tsai2
1Department of Palliative, Rehabilitation, and Integrative Medicine, MD Anderson Cancer Center, Houston, Texas.
基于洛拉泽帕姆的计划治疗方案有效地减少了晚期癌症和痴呆症的息护理患者的激动和不安. 这项研究比较了halooperidol,lorazepam,组合治疗和安慰剂,发现lorazepam优于halooperidol和安慰剂.
科学领域:
- 抚慰性护理医学 抚慰性护理医学
- 在瘤学瘤学.
- 心理药理学 心理药理学
背景情况:
- 激动性妄想在晚期癌症患者中很常见,通常用神经质药和二类药物进行治疗.
- 这些药物的风险-益处概况尚不清楚,对二zepines的有限的安慰剂控制数据.
研究的目的:
- 为了比较计划的利,洛拉泽帕姆,组合疗法和安慰剂,用于管理狂妄症的晚期癌症患者的不安和兴奋.
- 评估不同镇静剂方案在息护理环境中的有效性和安全性.
主要方法:
- 多中心随机临床试验涉及111名患有晚期癌症的患者,他们经历了持续的激动.
- 患者每4小时接受预定静脉注射的利,洛拉泽帕姆,利加洛拉泽帕姆或安慰剂.
- 主要结局是里士满兴奋镇静量表 (RASS) 24小时内得分的变化.
主要成果:
- 与haloperidol相比,洛拉泽巴姆和组合疗法显著降低了RASS得分.
- 与安慰剂相比,Haloperidol在RASS得分降低方面没有显著差异.
- 与利和安慰剂相比,基于洛拉泽帕姆的疗法需要较少的救援药物来治疗突破性激动.
结论:
- 基于洛拉泽帕姆的计划治疗方案有效地减少了患有妄想症的晚期癌症患者的不安和动荡.
- 洛拉泽帕姆的积极使用可能是缓和护理中管理激动性妄想的有益策略.
更多相关视频
03:02Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
相关概念视频
Stages of General Anesthesia
Parenteral Anesthetics: Overview
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
